| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.01 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |